Literature DB >> 11234976

Group A streptococcus clones causing repeated epidemics and endemic disease in intravenous drug users.

P Léchot1, H J Schaad, S Graf, M Täuber, K Mühlemann.   

Abstract

Clones of Group A streptococcus (GAS) may spread epidemically and may be associated with enhanced virulence. Sociodemographic and clinical characteristics, together with bacterial isolates, of 79 patients with GAS infection in the Berne region between January 1993 and February 1997 were analysed retrospectively. Using pulsed-field gel electrophoresis, most strains (71%) were found to belong to one of 12 clones. Clonal strains caused significantly more frequent skin abscesses and more severe invasive disease than non-clonal strains. The largest clone (M serotype 1) occurred endemically in non-IVDU patients and caused severe disease in most. Three clones occurred almost exclusively among IVDUs: an M serotype 11 was associated with severe, endemic disease; the other 2 clones, both of M serotype 25, caused epidemics of needle abscesses. Epidemic and endemic spread of GAS clones among IVDUs may be more frequent than previously assumed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11234976

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  An internationally spread clone of Streptococcus pneumoniae evolves from low-level to higher-level penicillin resistance by uptake of penicillin-binding protein gene fragments from nonencapsulated pneumococci.

Authors:  Christoph Hauser; Suzanne Aebi; Kathrin Mühlemann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Use of the Agilent 2100 bioanalyzer for rapid and reproducible molecular typing of Streptococcus pneumoniae.

Authors:  Lucy J Hathaway; Silvio Brugger; Alina Martynova; Suzanne Aebi; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

3.  Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting.

Authors:  Karen F McGregor; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.

Authors:  Tetyana I Vasylyeva; Pavlo Smyrnov; Steffanie Strathdee; Samuel R Friedman
Journal:  J Int AIDS Soc       Date:  2020-07       Impact factor: 5.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.